A pilot study of N-methyl-D-aspartate (NMDA) antagonist in Parkinson's disease.
AUTOR(ES)
Montastruc, J L
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=489186Documentos Relacionados
- N-methyl-D-aspartate (NMDA) antagonists in Parkinson's disease.
- Calcium-mediated modulation of N-methyl-D-aspartate (NMDA) responses in cultured rat hippocampal neurones.
- Glycine decreases desensitization of N-methyl-D-aspartate (NMDA) receptors expressed in Xenopus oocytes and is required for NMDA responses.
- Long-term age-dependent behavioral changes following a single episode of fetal N-methyl-D-Aspartate (NMDA) receptor blockade
- Cofactors of serine racemase that physiologically stimulate the synthesis of the N-methyl-d-aspartate (NMDA) receptor coagonist d-serine